+ All Categories
Home > Documents > CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive...

CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive...

Date post: 19-Mar-2020
Category:
Upload: others
View: 0 times
Download: 0 times
Share this document with a friend
16
CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 204623Orig1s000 CHEMISTRY REVIEW(S)
Transcript
Page 1: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA

CENTER FOR DRUG EVALUATION AND

RESEARCH

APPLICATION NUMBER:

204623Orig1s000

CHEMISTRY REVIEW(S)

Page 2: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA
Page 3: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA
Page 4: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA
Page 5: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA
Page 6: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA

---------------------------------------------------------------------------------------------------------This is a representation of an electronic record that was signedelectronically and this page is the manifestation of the electronicsignature.---------------------------------------------------------------------------------------------------------/s/----------------------------------------------------

YONG HU02/08/2013

PRASAD PERI02/08/2013I concur

Reference ID: 3258383

Page 7: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA
Page 8: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA
Page 9: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA
Page 10: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA
Page 11: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA
Page 12: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA
Page 13: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA
Page 14: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA
Page 15: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA
Page 16: CENTER FOR DRUG EVALUATION AND RESEARCH · The Chemistry Review for NDA 202450 The Executive Summary I. Recommendations A. Recommendation and Conclusion on Approvability This NDA

---------------------------------------------------------------------------------------------------------This is a representation of an electronic record that was signedelectronically and this page is the manifestation of the electronicsignature.---------------------------------------------------------------------------------------------------------/s/----------------------------------------------------

YONG HU02/01/2013Corrected version.

PRASAD PERI02/01/2013I concur

Reference ID: 3254049


Recommended